Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Geroni

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|March 6, 1999
Ring-B modified anthracyclinesA Suarato, F Angelucci, C Geroni
British Journal of Cancer|September 1, 1986
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicinM Grandi, C Geroni, F C Giuliani
Drugs Under Experimental and Clinical Research|January 1, 1986
In vitro studies on anthracycline haloderivativesT Facchinetti, C Geroni, A Fumagalli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell lineO Cantoni, P Sestili, F Cattabeni, et al.
Biochemical Pharmacology|November 1, 1989
Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)G Belvedere, A Suarato, C Geroni, et al.
Journal of Natural Products|September 1, 1986
Cytotoxic and antitumor activity of vismiones isolated from vismieaeG Cassinelli, C Geroni, B Botta, et al.
Anti-Cancer Drug Design|August 1, 1988
Studies of anthracycline--DNA complexes by circular dichroismV Rizzo, S Penco, M Menozzi, et al.
Journal of Medicinal Chemistry|September 1, 1987
Improved synthesis and antitumor activity of 1-deazaadenosineG Cristalli, P Franchetti, M Grifantini, et al.
Anti-Cancer Drug Design|November 1, 1991
Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell linesI Facchetti, M Grandi, P Cucchi, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Cytotoxic halogenoacrylic derivatives of distamycin AP Cozzi, I Beria, M Caldarelli, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|March 6, 1999
Ring-B modified anthracyclinesA Suarato, F Angelucci, C Geroni
British Journal of Cancer|September 1, 1986
Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicinM Grandi, C Geroni, F C Giuliani
Drugs Under Experimental and Clinical Research|January 1, 1986
In vitro studies on anthracycline haloderivativesT Facchinetti, C Geroni, A Fumagalli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell lineO Cantoni, P Sestili, F Cattabeni, et al.
Biochemical Pharmacology|November 1, 1989
Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)G Belvedere, A Suarato, C Geroni, et al.
Journal of Natural Products|September 1, 1986
Cytotoxic and antitumor activity of vismiones isolated from vismieaeG Cassinelli, C Geroni, B Botta, et al.
Anti-Cancer Drug Design|August 1, 1988
Studies of anthracycline--DNA complexes by circular dichroismV Rizzo, S Penco, M Menozzi, et al.
Journal of Medicinal Chemistry|September 1, 1987
Improved synthesis and antitumor activity of 1-deazaadenosineG Cristalli, P Franchetti, M Grifantini, et al.
Anti-Cancer Drug Design|November 1, 1991
Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell linesI Facchetti, M Grandi, P Cucchi, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Cytotoxic halogenoacrylic derivatives of distamycin AP Cozzi, I Beria, M Caldarelli, et al.
Pageof 5